SW
ALXN

SVB Wealth’s Alexion Pharmaceuticals ALXN Stock Holding History

SVB Wealth’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,616
Closed -$297K – 1064
2021
Q2 		$297K Buy
1,616
+272
+20% +$46.7K ﹤0.01% 760
2021
Q1 		$206K Sell
1,344
-76
-5% -$11.8K ﹤0.01% 828
2020
Q4 		$221K Buy
+1,420
New +$182K ﹤0.01% 723
2016
Q2 		– Sell
-6,495
Closed -$904K – 528
2016
Q1 		$904K Sell
6,495
-591
-8% -$86.8K 0.04% 269
2015
Q4 		$1.35M Sell
7,086
-2,757
-28% -$482K 0.05% 240
2015
Q3 		$1.54M Sell
9,843
-74
-0.7% -$13.5K 0.06% 240
2015
Q2 		$1.79M Sell
9,917
-1,131
-10% -$195K 0.06% 249
2015
Q1 		$1.92M Sell
11,048
-887
-7% -$161K 0.06% 240
2014
Q4 		$2.21M Buy
+11,935
New +$2.21M 0.07% 223

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return